| Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison K Maman, S Aballea, J Nazir, K Desroziers, ME Neine, E Siddiqui, ... European urology 65 (4), 755-765, 2014 | 319 | 2014 |
| Efficacy and tolerability of mirabegron compared with antimuscarinic monotherapy or combination therapies for overactive bladder: a systematic review and network meta-analysis C Kelleher, Z Hakimi, R Zur, E Siddiqui, K Maman, S Aballéa, J Nazir, ... European urology 74 (3), 324-333, 2018 | 213 | 2018 |
| Subjective health status and health-related quality of life among women with recurrent vulvovaginal candidosis (RVVC) in Europe and the USA S Aballéa, F Guelfucci, J Wagner, A Khemiri, JP Dietz, J Sobel, M Toumi Health and quality of life outcomes 11, 1-13, 2013 | 138 | 2013 |
| Quality of life is predictive of relapse in schizophrenia L Boyer, A Millier, E Perthame, S Aballea, P Auquier, M Toumi BMC psychiatry 13, 1-8, 2013 | 133 | 2013 |
| Cataract in patients with diabetes mellitus—incidence rates in the UK and risk factors C Becker, C Schneider, S Aballéa, C Bailey, R Bourne, S Jick, C Meier Eye 32 (6), 1028-1035, 2018 | 116 | 2018 |
| Measuring health-related quality of life in young children: how far have we come? N Germain, S Aballéa, M Toumi Journal of Market Access & Health Policy 7 (1), 1618661, 2019 | 107 | 2019 |
| The real-life impact of vaccination on COVID-19 mortality in Europe and Israel K Jabłońska, S Aballéa, M Toumi Public Health 198, 230-237, 2021 | 90 | 2021 |
| The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model S Aballéa, J Chancellor, M Martin, P Wutzler, F Carrat, R Gasparini, ... Value in Health 10 (2), 98-116, 2007 | 86 | 2007 |
| Cost‐effectiveness analysis of oxaliplatin compared with 5‐fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US S Aballéa, JVM Chancellor, M Raikou, MF Drummond, MC Weinstein, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 76 | 2007 |
| Comparison of inhaled antibiotics for the treatment of chronic Pseudomonas aeruginosa lung infection in patients with cystic fibrosis: systematic literature review and network … JS Elborn, AL Vataire, A Fukushima, S Aballea, A Khemiri, C Moore, ... Clinical therapeutics 38 (10), 2204-2226, 2016 | 58 | 2016 |
| Patient survey to identify reasons for non-adherence and elicitation of quality of life concepts associated with immunosuppressant therapy in kidney transplant recipients G Muduma, FC Shupo, S Dam, NA Hawken, S Aballéa, I Odeyemi, ... Patient preference and adherence, 27-36, 2016 | 58 | 2016 |
| Association between social contact frequency and negative symptoms, psychosocial functioning and quality of life in patients with schizophrenia K Siegrist, A Millier, I Amri, S Aballéa, M Toumi Psychiatry research 230 (3), 860-866, 2015 | 54 | 2015 |
| An assessment of the expected cost-effectiveness of quadrivalent influenza vaccines in Ontario, Canada using a static model A Chit, J Roiz, S Aballea PLoS One 10 (7), e0133606, 2015 | 49 | 2015 |
| Burden of cytomegalovirus disease in solid organ transplant recipients: a national matched cohort study in an inpatient setting Z Hakimi, S Aballéa, S Ferchichi, M Scharn, IA Odeyemi, M Toumi, ... Transplant Infectious Disease 19 (5), e12732, 2017 | 48 | 2017 |
| Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens J Chancellor, S Aballéa, A Lawrence, R Sheldon, S Cure, J Plun-Favreau, ... Pharmacoeconomics 26, 217-234, 2008 | 46 | 2008 |
| A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients V Taieb, H Ikeoka, FF Ma, K Borkowska, S Aballea, K Tone, N Hirotsu Current Medical Research and Opinion, 2019 | 45 | 2019 |
| A critical literature review of health economic evaluations of rotavirus vaccination S Aballéa, A Millier, S Quilici, S Caroll, S Petrou, M Toumi Human vaccines & immunotherapeutics 9 (6), 1272-1288, 2013 | 45 | 2013 |
| A comparison of HAS & NICE guidelines for the economic evaluation of health technologies in the context of their respective national health care systems and cultural environments M Massetti, S Aballéa, Y Videau, C Rémuzat, J Roïz, M Toumi Journal of market access & health policy 3 (1), 24966, 2015 | 41 | 2015 |
| The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: A model-based analysis for Spain S Aballéa, JR De Juanes, M Barbieri, M Martin, J Chancellor, I Oyagüez, ... Vaccine 25 (39-40), 6900-6910, 2007 | 40 | 2007 |
| Routine clinical assessment of cognitive functioning in schizophrenia, major depressive disorder, and bipolar disorder W Belgaied, J Samp, A Vimont, C Rémuzat, S Aballéa, E El Hammi, ... European Neuropsychopharmacology 24 (1), 133-141, 2014 | 39 | 2014 |
